In light of the recent editorial on changing paediatric sedation practice 1, we would like to offer our comments and share our experience of starting a radiology sedation service using dexmedetomidine. The UK Activity Survey estimated that 10,000 children in the UK were sedated by anaesthetists, but was a survey of anaesthetist activity alone, and did not include the activity of dentists, gastro-enterologists, paediatricians (in radiology areas), or emergency physicians 2. We believe that a larger number of children were, and still are, sedated by non-anaesthetists, although we do not have data to quantify this. Secondly, we agree that the definitions of sedation do not help to describe a child who is asleep and remains undisturbed for a successful painless procedure. We do not agree, however, that they should be easily rousable. We have a long experience of managing small children with chloral hydrate safely and we do not truly know their depth of sedation during the scans, although we doubt that they are easily roused since many MRI sequences are stimulating. Thirdly, 10,000 children spread across the UK is a rather small workload for enabling anaesthetic trainees to gain experience. In our hospital, we do not teach sedation to our trainees because so few of us do it. Sedative premedication is not the same as sedation for a procedure, because each type of procedure has specific requirements. Emergency physicians require a range of sedation techniques and should have the skills to manage emergency situations. Gastro-enterologists have specific needs that may benefit from conventional anaesthesia drugs. Dentists are already organised and can teach us much about sedation. Nonetheless, anaesthetists can help to organise an effective sedation service carried out by non-anaesthetists. It is radiology departments that may benefit from our involvement with sedation and we agree with Dr. Bailey that dexmedetomidine could be extremely useful to them. Whilst dexmedetomidine has been in clinical use for well over a decade, it has only been available in the UK since October 2011 3. Despite a strong evidence base in support of the efficacy and safety of this drug 4, its uptake in the UK seems to be slower, possibly relating to its high cost. At our institution, dexmedetomidine has been available for clinical use since September 2013, and it has been available as an intranasal premedication since March 2015. We have successfully operated a nurse-led MRI sedation service using well established protocols since 1999 5. We have recently piloted intravenous dexmedetomidine as a sedative agent for 10 children undergoing MRI scans using the Boston sedation protocol (3 μg.kg−1 loading dose over 10 min, followed by 2 μg.kg−1.h−1 infusion) 6. Although currently supported by a specialist paediatric anaesthetist, our goal is to develop this into a nurse-led service. Since all children require intravenous access to proceed, and this is not always easy in the awake child, we do not anticipate this service replacing our general anaesthetic service but rather supporting it. As a tertiary paediatric institution, we have been particularly satisfied with the safety and efficacy of dexmedetomidine in these early phases of its introduction into our patient population, but we agree that larger trials are required to establish this, since most anaesthetic uses for this drug remain off-label. Like Dr. Bailey, we foresee a significant increase in its use in the UK and it is certain to change the practice of paediatric sedation.